Tandem Diabetes Care, Inc. (TNDM) Financial Analysis & Valuation | Quarter Chart
Tandem Diabetes Care, Inc. (TNDM)
TNDMPrice: $24.57
Fair Value: 🔒
🔒score
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that compris... more
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various ... more
Description
Shares
| Market Cap | $1.67B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | John F. Sheridan |
| IPO Date | 2013-11-14 | CAGR | — |
| Employees | 2,650 | Website | www.tandemdiabetes.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
TNDM chart loading...
Fundamentals
Technicals
| Enterprise Value | $1.49B | P/E Ratio | -5.28 |
| Forward P/E | -1014.28 | PEG Ratio | — |
| P/S Ratio | 1.64 | P/B Ratio | 12.57 |
| P/CF Ratio | -171.89 | P/FCF Ratio | -72.48 |
| EPS | $-3.08 | EPS Growth 1Y | 110.48% |
| EPS Growth 3Y | 108.84% | EPS Growth 5Y | 387.3% |
| Revenue Growth 1Y | -4.23% | Gross Margin | 0.54% |
| Operating Margin | -0.09% | Profit Margin | -0.2% |
| ROE | -1.2% | ROA | -0.23% |
| ROCE | -0.15% | Current Ratio | 2.44 |
| Quick Ratio | 1.9 | Cash Ratio | 0.36 |
| Debt/Equity | 3.38 | Interest Coverage | -15.45 |
| Altman Z Score | -0.05 | Piotroski Score | 2 |